Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,013,832
+$591,139 QoQ
Shares Held
114,724
+16.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#146
of 1,033 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stamos Capital Partners, L.P. holds $64,248,987 across 8 Drug Manufacturers - General names. GSK ranks #6 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
179,799 | $23,104,171 | |
| 2 | JNJ |
Johnson & Johnson
|
43,175 | $10,965,154 | |
| 3 | NVO |
Novo Nordisk A S
|
184,608 | $8,850,107 | |
| 4 | PFE |
Pfizer Inc
|
297,285 | $7,158,622 | |
| 5 | LLY |
ELI LILLY & Co
|
5,449 | $6,535,694 | |
| 6 | GSK |
GSK plc
This page
|
114,724 | $6,013,832 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,763 | $854,437 | |
| 8 | AMGN |
Amgen Inc
|
2,118 | $766,970 |
All Filings in GSK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,013,832 | 114,724 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,422,693 | 98,255 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,893,774 | 120,183 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,923,019 | 137,234 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,142,092 | 185,992 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,631,982 | 145,379 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,970,812 | 294,820 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,469,927 | 207,190 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,333,480 | 190,480 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,186,026 | 190,950 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,343,560 | 171,170 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,752,237 | 103,510 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,341,962 | 93,770 | Shares | Sole | 2023-08-11 | |
| 2022-09-30 | $2,016,837 | 68,530 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,239,985 | 193,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,245,664 | 193,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,873,795 | 135,800 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,912,158 | 104,390 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,076,999 | 104,390 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,700,002 | 105,700 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,815,076 | 105,700 | Shares | Sole | 2021-02-12 | |
| 2020-03-31 | $1,013,719 | 27,278 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||